BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1091741)

  • 1. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
    Germain RN; Williams RM; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
    Williams RM; Germain RN; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ; Kataoka T; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells.
    Bucana C; Hoyer LC; Hobbs B; Breesman S; McDaniel M; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4444-58. PubMed ID: 187323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonspecific cytotoxicity of vaccinia-induced peritoneal exudates in hamsters is mediated by Thy-1.2 homologue-positive cells distinct from NK cells and macrophages.
    Yang H; Tompkins WA
    J Immunol; 1983 Nov; 131(5):2545-50. PubMed ID: 6195269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of peritoneal exudate cells induced by cell-wall skeleton of Mycobacterium bovis BCG.
    Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
    Gan; 1978 Dec; 69(6):831-4. PubMed ID: 374173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum.
    Tomecki J; Sukiennik J; Kordowiak A
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Destruction of tumor cells by BCG-activated alqolar macrophages.
    Zwilling BS; Campolito LB
    J Immunol; 1977 Sep; 119(3):838-41. PubMed ID: 330756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro induction of polyclonal killer T cells with 2-mercaptoethanol and the essential role of macrophages in this process.
    Igarashi T; Okada M; Kishimoto T; Yamamura Y
    J Immunol; 1977 May; 118(5):1697-703. PubMed ID: 67145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG.
    Tracey DE; Wolfe SA; Durdik JM; Henney CS
    J Immunol; 1977 Sep; 119(3):1145-51. PubMed ID: 330748
    [No Abstract]   [Full Text] [Related]  

  • 12. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antitumor effects of BCG and monoclonal antibodies capable of inducing antibody-dependent cell-mediated cytotoxicity.
    Komuta K; Kawase I; Ogura T; Masuno T; Yokota S; Hosoe S; Ikeda T; Shirasaka T; Kishimoto S
    Jpn J Cancer Res; 1987 Feb; 78(2):185-92. PubMed ID: 3104261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytotoxic effect of BCG-activated macrophages on tumor target cells in vitro].
    Viadro MM
    Biull Eksp Biol Med; 1979 Jan; 87(1):36-9. PubMed ID: 760842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG.
    Meltzer MS; Stevenson MM
    J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142
    [No Abstract]   [Full Text] [Related]  

  • 16. Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.
    Piessens WF; Churchill WH; David
    J Immunol; 1975 Jan; 114(1 Pt 2):293-9. PubMed ID: 163856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
    Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
    J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells.
    Drapier JC; Hibbs JB
    J Immunol; 1988 Apr; 140(8):2829-38. PubMed ID: 2451695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated macrophages and the antitumor action of BCG.
    Alexander P
    Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP).
    Kato K; Yamamoto K; Kimura T; Azuma I; Askenase PW
    J Immunol; 1984 Jun; 132(6):2790-5. PubMed ID: 6202761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.